Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : PRESIDENT GEORGE W. BUSH -- Ignore unavailable to you. Want to Upgrade?

To: Red Heeler who wrote (456772)	9/11/2003 12:57:22 AM
From: Doug R	Read Replies (1) \| Respond to of 769670

"In the absence of FDA approval of a product for a specific countermeasure use, the BioShield bill permits the HHS Secretary to issue an emergency authorization that would provide Americans with access to certain unlicensed countermeasures. " "FDA regulations are stringent when it comes to informed consent for investigational products. Because urgent situations may require mass inoculations and/or drug treatments, such informed consent requirements may prove impossible to implement within the necessary time frame when trying to achieve the public health goal of protecting Americans from the imminent danger. The legislation would provide for the Secretary to impose conditions on the authorization, either by regulation or on a case-by-case basis, where appropriate to protect public health. Specifically, the bill provides that such conditions shall include labeling and other requirements to ensure that health care professionals are informed of the special emergency nature of the authorization; of the benefits and risks (and the extent to which such benefits and risks are unknown)" "the conditions of authorization may include the following: requirements, or waiver of otherwise-applicable requirements, regarding good manufacturing practice; and requirements for monitoring and reporting adverse events." hhs.gov a million to one that an attack somewhere in the US would adversely affect my health. probably 50 to one that ingesting unapproved, experimental, poorly manufactured drugs WILL adversely affect my health.

To: Red Heeler who wrote (456772)	9/11/2003 1:23:55 AM
From: Doug R	Read Replies (1) \| Respond to of 769670

At a recent meeting with editorial writers from The Washington Times, Raymond Gilmartin, CEO of Merck & Co., said that one of the best ways Congress could encourage the development of anti-bioterrorism vaccines would be passage of Project Bioshield. While pharmaceutical companies said that they would have preferred that provisions limiting liability be kept in the bills, they proved too controversial in both chambers. washtimes.com use of the media to make a sales pitch corporatism in govt policy for profit If it's a PATRIOTIC goal...do it for free...same goes for halliburton